2.03
Schlusskurs vom Vortag:
$1.98
Offen:
$1.99
24-Stunden-Volumen:
498.98K
Relative Volume:
0.30
Marktkapitalisierung:
$70.12M
Einnahmen:
$300.00K
Nettoeinkommen (Verlust:
$-24.74M
KGV:
-2.0179
EPS:
-1.006
Netto-Cashflow:
$-19.19M
1W Leistung:
+18.71%
1M Leistung:
-22.22%
6M Leistung:
+138.88%
1J Leistung:
-37.05%
iBio Inc Stock (IBIO) Company Profile
Firmenname
iBio Inc
Sektor
Branche
Telefon
302-355-0650
Adresse
600 Madison Avenue, Suite 1601, New York, NY
Compare IBIO vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
IBIO
iBio Inc
|
2.03 | 68.40M | 300.00K | -24.74M | -19.19M | -1.006 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.30 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
763.04 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
748.25 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
330.34 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
INSM
Insmed Inc
|
163.81 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-21 | Eingeleitet | Oppenheimer | Outperform |
| 2025-10-17 | Eingeleitet | Leerink Partners | Outperform |
| 2024-05-28 | Eingeleitet | Chardan Capital Markets | Buy |
| 2021-11-29 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-01-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-06-26 | Eingeleitet | Alliance Global Partners | Buy |
Alle ansehen
iBio Inc Aktie (IBIO) Neueste Nachrichten
Aug Selloffs: Will iBio Inc benefit from green energy policiesInsider Selling & Real-Time Buy Zone Alerts - baoquankhu1.vn
Top iBio (IBIO) Competitors 2026 - MarketBeat
FRA:0JV0 PB Ratio: 1.01 — 33% Below Median - GuruFocus
IBIO Should I Buy - Intellectia AI
iBio Inc. (0JV0.SG) cash flow - Yahoo Finance UK
IBIO Stock Price, Quote & Chart | IBIO INC (NASDAQ:IBIO) - ChartMill
Can iBio Inc stock double in the next yearQuarterly Performance Summary & Entry and Exit Point Strategies - baoquankhu1.vn
Insider List - GuruFocus
Insider Buying: Marc Banjak Acquires Additional Shares of iBio I - GuruFocus
iBio chief legal officer Banjak buys shares worth $23,055 By Investing.com - Investing.com South Africa
iBio chief legal officer Banjak buys shares worth $23,055 - Investing.com
Insider Banjak Marc buys 13,934 iBio (IBIO) shares in open market - Stock Titan
Leerink reiterates Outperform on iBio stock amid competitor data By Investing.com - Investing.com South Africa
Leerink reiterates Outperform on iBio stock amid competitor data - Investing.com
IBIO PB Ratio: 0.91 — 41% Below Median - GuruFocus
IBIO Plummets Nearly 21%: A Biotech Ticker Stumbles in the Face of Technical Breakdown - Bitget
These stocks that are showing activity before the opening bell on Thursday. - ChartMill
Panic Selling: Is iBio Inc impacted by rising ratesWeekly Stock Recap & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Insider Buying: Felipe Duran Acquires Shares of iBio Inc (IBIO) - GuruFocus
iBio CFO Duran acquired $50k in shares on March 19 - Investing.com India
INB.bio Launches Rebuilt Ai-Powered Affiliate Crm Platform - MarketScreener
Martin Brenner Purchases 12,336 Shares of iBio (NASDAQ:IBIO) Stock - MarketBeat
iBio (NASDAQ:IBIO) CFO Felipe Duran Acquires 24,835 Shares - MarketBeat
iBio director Brenner buys $24918 in company stock By Investing.com - Investing.com Australia
iBio director Brenner buys $24918 in company stock - investing.com
iBio CFO Duran acquired $50k in shares on March 19 By Investing.com - Investing.com Australia
IBIO | iBio, Inc. Common Stock Insider Trading - Quiver Quantitative
CFO adds 24,835 iBio (NYSE: IBIO) shares in open-market purchase - Stock Titan
iBio (IBIO) director makes open-market purchase of 12,336 shares - Stock Titan
Aug Action: Is iBio Inc a speculative investmentTrade Analysis Report & Weekly High Return Forecasts - baoquankhu1.vn
Ibio (IBIO) Receives a Buy from LifeSci Capital - The Globe and Mail
History Review: Can iBio Inc stock double in the next yearTake Profit & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
iBio (NASDAQ:IBIO) Cut to Sell at Wall Street Zen - MarketBeat
Aug Movers: Is iBio Inc impacted by rising rates2026 Earnings Surprises & Weekly Top Stock Performers List - baoquankhu1.vn
iBio Touts Bispecific Antibody Strategy for PH-HFpEF, Eyes Development Candidate in Q3 - MarketBeat
IBIO Technical Analysis | Trend, Signals & Chart Patterns | IBIO INC (NASDAQ:IBIO) - ChartMill
Chardan Capital Maintains IBio Inc(IBIO.US) With Buy Rating, Maintains Target Price $5 - 富途牛牛
IBIO: Analyst Keay Nakae Reaffirms 'Buy' Rating with $5.00 Price Target | IBIO Stock News - GuruFocus
Aug Opening: How do insiders feel about iBio IncQuarterly Trade Report & Low Drawdown Trading Strategies - baoquankhu1.vn
Jones Trading reiterates iBio stock rating on pulmonary hypertension expansion By Investing.com - Investing.com South Africa
Jones Trading reiterates iBio stock rating on pulmonary hypertension expansion - Investing.com India
VIX Spike: Is IBIO in a long term uptrend2026 PreEarnings & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
iBio (NASDAQ:IBIO) Given Buy Rating at Chardan Capital - MarketBeat
iBio (IBIO) to Discuss Pipeline Expansion in Upcoming Conference Call - GuruFocus
iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) - The Manila Times
Stop Loss: How sensitive is iBio Inc to inflationWeekly Gains Report & Real-Time Chart Pattern Alerts - baoquankhu1.vn
iBio to Provide an Update on Cardiopulmonary Program - GlobeNewswire
iBio reports fat reduction in primate obesity study By Investing.com - Investing.com Nigeria
Ibio SEC Filings - Stock Titan
Finanzdaten der iBio Inc-Aktie (IBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
iBio Inc-Aktie (IBIO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Duran Felipe | Chief Financial Officer |
Mar 19 '26 |
Buy |
2.02 |
24,835 |
50,132 |
35,974 |
| Brenner Martin | See Remarks |
Mar 19 '26 |
Buy |
2.02 |
12,336 |
24,919 |
30,652 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):